# BRIEFING — 2026-09-06T08:21:55+09:00

## Mission
Investigate evaluation scripts, benchmarks, test suites, and comparison reports to guide Phase 18 verification (Baseline & Benchmark Explorer).

## 🔒 My Identity
- Archetype: explorer
- Roles: investigator, synthesizer
- Working directory: d:\Finance\code\stock\.agents\explorer_phase18_baseline_1
- Original parent: 2f437bef-b236-4e44-8d12-f9727cc62757
- Milestone: Phase 18 Quant Enhancement Baseline & Benchmark Exploration

## 🔒 Key Constraints
- Read-only investigation — do NOT implement
- Follow AGENTS.md and ORIGINAL_REQUEST.md guidelines
- Write analysis and handoff report to working directory
- Communicate with parent via send_message

## Current Parent
- Conversation ID: 2f437bef-b236-4e44-8d12-f9727cc62757
- Updated: 2026-09-06T08:21:55+09:00

## Investigation State
- **Explored paths**:
  - `ORIGINAL_REQUEST.md` (authoritative request for Phase 18, lines 476-514)
  - `trading_system/scripts/benchmark_phase17_quant_performance.py` & `benchmark_phase16_quant_performance.py`
  - `tests/test_benchmark_phase17.py`, `test_phase17_signal_enhancement.py`, `test_phase17_risk_allocation.py`, `test_phase17_microstructure_oms.py`, `test_phase17_challenger_stress_alpha_risk.py`, `test_phase17_challenger_stress_oms_benchmark.py`
  - `reports/quant_benchmark_comparison_phase17.md` & `reports/quant_benchmark_comparison.md`
- **Key findings**:
  - Phase 18 Baseline is strictly Phase 17 Enhancement (100.10% net return, 13.45 Sharpe, -0.07% MDD, 0.25 bps friction, 0.01 bps slippage, 70.2% top spread).
  - Phase 18 Targets: Net Return >= 101.5% (Achieved target: 102.25%), Sharpe >= 13.80 (Achieved target: 14.05), MDD <= -0.06% (Achieved target: -0.05%), Friction <= 0.22 bps (Achieved target: 0.18 bps), Slippage <= 0.01 bps (Achieved target: 0.008 bps), Top-Decile Spread >= 71.5% (Achieved target: 72.5%).
  - 5-market simulation scope with canonical weights: SP500 (40%), NASDAQ (25%), KOSPI (15%), KOSDAQ (10%), RUSSELL2000 (10%).
  - 3 standard tables layout, calculation methodologies, and attribution mapping (Features F91~F94) fully mapped.
  - Complete test coverage blueprint designed across unit and adversarial challenger stress suites.
  - Multi-path report synchronization protocol verified for `reports/quant_benchmark_comparison_phase18.md` and `reports/quant_benchmark_comparison.md`.
- **Unexplored areas**: Implementation and code modifications (handed off to implementation team).

## Key Decisions Made
- Fully documented Phase 18 baseline and targets in `handoff.md`.
- Outlined exact specifications for `benchmark_phase18_quant_performance.py` and test suites.

## Artifact Index
- [d:\Finance\code\stock\.agents\explorer_phase18_baseline_1\DISPATCH.md] — Inbound dispatch record
- [d:\Finance\code\stock\.agents\explorer_phase18_baseline_1\BRIEFING.md] — Situational awareness
- [d:\Finance\code\stock\.agents\explorer_phase18_baseline_1\progress.md] — Liveness heartbeat
- [d:\Finance\code\stock\.agents\explorer_phase18_baseline_1\handoff.md] — 5-component handoff report
